Product NDC: | 25021-109 |
Proprietary Name: | Cefoxitin |
Non Proprietary Name: | cefoxitin sodium |
Active Ingredient(s): | 1 g/1 & nbsp; cefoxitin sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | POWDER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-109 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065414 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091105 |
Package NDC: | 25021-109-10 |
Package Description: | 10 VIAL in 1 CARTON (25021-109-10) > 1 POWDER in 1 VIAL |
NDC Code | 25021-109-10 |
Proprietary Name | Cefoxitin |
Package Description | 10 VIAL in 1 CARTON (25021-109-10) > 1 POWDER in 1 VIAL |
Product NDC | 25021-109 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefoxitin sodium |
Dosage Form Name | POWDER |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091105 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | CEFOXITIN SODIUM |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |